Using a genetically engineered mouse model (GEMM) for SCLC, we find that both Carm1 conditional loss and NfibR388K knock-in results in a significant increase in survival, and the tumors derived from these two models display very similar patterns of open chromatin. This evidence concerns the gene CARM1 and small cell lung carcinoma.